動物治療和診斷市場規模、佔有率及成長分析（按產品、技術、應用、動物類型、最終用途和地區）－產業預測，2025-2032

預計 2023 年全球獸醫治療診斷市場價值將達到 473 億美元，從 2024 年的 502.8 億美元成長到 2032 年的 819.7 億美元，預測期內（2025-2032 年）的複合年成長率為 6.3%。

全球動物治療診斷市場正經歷顯著成長，這得益於技術創新、嚴格的監管標準以及對增強型動物健康解決方案日益成長的需求。關鍵發展包括智慧診斷系統的進步，以及專注於最佳化效能和改善供應鏈管理的人工智慧主導技術的整合。這些創新從根本上改變了動物健康數據的處理和使用方式，促進了對特定動物物種和健康狀況的即時洞察，同時確保符合監管要求。機器學習和人工智慧的整合正在改善數據傳播，並使行業領導者和研究人員能夠實施高度精準的建議，最終推動獸醫學的進步並提升整體動物福利。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管格局
• 客戶和購買標準分析

獸醫治療及診斷試劑市場規模（依產品分類）及複合年成長率（2025-2032）

• 市場概況
• 耗材
• 裝置

獸醫治療及診斷市場規模（依技術分類）及複合年成長率（2025-2032）

• 市場概況
• 臨床生物化學
  • 血糖監測
  • 血氣和電解質分析
  • 其他臨床生物化學檢驗
• 免疫診斷
  • 橫向流動化驗
  • ELISA
  • 免疫檢測分析儀
  • 其他免疫診斷測試
• 分子診斷
  • PCR
  • 微陣列
  • 其他分子診斷測試
• 血液學
• 尿液檢查
• 其他技術

獸醫治療及診斷試劑市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 細菌學
• 病理
• 寄生蟲學
• 其他用途

動物治療及診斷市場規模（依動物類型分類）及複合年成長率（2025-2032）

• 市場概況
• 寵物
  • 狗
  • 貓
  • 馬
  • 其他伴侶動物
• 農場動物
  • 牛
  • 豬
  • 家禽
  • 其他牲畜

動物治療及診斷市場規模（依最終用途分類）及複合年成長率（2025-2032）

• 市場概況
• 獸醫醫院和診所
• 診斷實驗室
• 居家照護環境
• 其他用途

獸醫治療及診斷市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比比較（2022-2024 年）

主要企業簡介

• Zoetis（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim（Germany）
• Elanco（USA）
• IDEXX Laboratories（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Dechra Pharmaceuticals（UK）
• Vetoquinol（France）
• Phibro Animal Health（USA）
• Heska Corporation（USA）
• Neogen（USA）
• Covetrus（USA）
• Thermo Fisher Scientific（USA）
• ImmuCell（USA）
• B. Braun Vet Care（Germany）
• Huvepharma（Bulgaria）
• Indian Immunologicals Limited（India）
• Zoetis Animal Health India Pvt. Ltd.（India）
• Inmed Animal Health（India）

結論和建議

Global Animal Therapeutics Diagnostics Market size was valued at USD 47.3 billion in 2023 and is poised to grow from USD 50.28 billion in 2024 to USD 81.97 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global animal therapeutics diagnostics market is experiencing significant growth fueled by technological innovations, stringent regulatory standards, and a rising demand for enhanced animal health solutions. Key developments include the advancement of intelligent diagnostic systems and the integration of AI-driven technologies, which focus on optimizing performance and improving supply chain management. These innovations have fundamentally transformed how animal health data is processed and utilized, facilitating real-time insights tailored to specific species and health conditions while ensuring compliance with regulatory requirements. The confluence of machine learning and artificial intelligence has improved data dissemination and empowered industry leaders and researchers to implement hyper-targeted recommendations, ultimately advancing the veterinary landscape and enhancing overall animal welfare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Therapeutics Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Therapeutics Diagnostics Market Segments Analysis

Global Animal Therapeutics Diagnostics Market is segmented by Product, Technology, Application, Animal Type, End Use and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Molecular diagnostics, Hematology, Urinalysis and Other technologies. Based on Application, the market is segmented into Bacteriology, Pathology, Parasitology and Other applications. Based on Animal Type, the market is segmented into Companion animals and Farm animals. Based on End Use, the market is segmented into Veterinary hospitals and clinics, Diagnostic labs, Home care settings and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Therapeutics Diagnostics Market

The landscape of companion animals is witnessing significant growth as a global transformation in attitudes positions pets as cherished family members, particularly in regions such as North America, Europe, and Asia-Pacific. This evolving perception has propelled the animal therapeutics diagnostics market, particularly in developed countries with higher disposable incomes. Simultaneously, in developing nations, an increasing pet population is driving owners to seek enhanced care standards for their animals. This dual trend of rising demand and improved spending capacity is fostering substantial market penetration and innovation within the animal therapeutics diagnostics sector.

Restraints in the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market faces a notable constraint due to the high initial investment required for advanced therapeutics, such as biologics and cell-based therapies, alongside sophisticated diagnostic equipment. While these innovations are recognized for their remarkable efficacy and personalized outcomes, the associated costs can be a barrier, particularly for small independent veterinary clinics and in developing countries. This pricing pressure may hinder broader adoption, as smaller entities often struggle to incorporate these premium solutions. Consequently, the market's growth potential is limited, with uptake primarily concentrated among larger veterinary hospitals and research institutions unless more affordable and scalable alternatives are introduced.

Market Trends of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is witnessing a transformative shift driven by the burgeoning adoption of digital platforms in animal health management. This evolution is primarily fueled by the pet-tech boom and an increasing demand for enhanced diagnostic efficiency. As veterinary practices integrate smart, connected solutions, the landscape is evolving, especially within companion animal and livestock management sectors. This trend not only improves diagnostic processes but also enhances overall health management, leading to better outcomes for animals. Consequently, stakeholders in the animal health industry are focusing on innovative technologies that will redefine traditional practices and propel the market forward.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Global Animal Therapeutics Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments

Global Animal Therapeutics Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Clinical biochemistry
  • Glucose monitoring
  • Blood gas and electrolyte analysis
  • Other clinical biochemistry tests
• Immunodiagnostics
  • Lateral flow assays
  • ELISA
  • Immunoassay analyzers
  • Other immunodiagnostic tests
• Molecular diagnostics
  • PCR
  • Microarrays
  • Other molecular diagnostic tests
• Hematology
• Urinalysis
• Other technologies

Global Animal Therapeutics Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bacteriology
• Pathology
• Parasitology
• Other applications

Global Animal Therapeutics Diagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Farm animals
  • Cattle
  • Swine
  • Poultry
  • Other farm animals

Global Animal Therapeutics Diagnostics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end use

Global Animal Therapeutics Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, Animal Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Application, Animal Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, Animal Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, Animal Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, Animal Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ImmuCell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Vet Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Animal Health India Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inmed Animal Health (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations